ARVN Stock Analysis: Buy, Sell, or Hold?

ARVN - Arvinas, Inc

PHARMACEUTICAL PREPARATIONS
$8.39
0.19 (2.32%) ▲
5d: +4.48%
30d: +4.88%
90d: -25.95%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026

Get Alerted When ARVN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: ARVN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ARVN is currently trading at $8.39, which is considered fair relative to its 30-day fair value range of $7.39 to $8.74.

Technical Outlook: Technically, ARVN is in a strong downtrend. Immediate support is located at $7.48, while resistance sits at $8.67.

Market Sentiment: ARVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.80 (+76.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $7.39 - $8.74
Company Quality Score 51/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 76.4% below Wall St target ($14.80)

Trading Range Analysis

30-Day Trading Range $7.39 - $8.74
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $7.48
Resistance Level $8.67
Current Trend Strong Downtrend
Technical data as of Jul 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) -2.43
Wall Street Target $14.80 (+76.4%)
Revenue Growth (YoY) -91.7%
Profit Margin -247.5%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 03, 2026 11:01 PM ET
Data refreshes hourly during market hours. Next update: 12:01 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
1
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Noah Berkowitz SELL 6435 shares 2026-03-18
Briggs Morrison BUY 20000 shares 2026-03-06
John G Houston SELL 35297 shares 2026-02-27

Unlock Insider Activity

See real-time buying/selling by company executives for ARVN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$27 55 HOLD
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$412 59 HOLD
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$833 63 BUY
VKTX
Viking Therapeutics Inc
STRONG BUY
19 analysts
$93 63 BUY
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD

Advanced ARVN Option Strategies

Professional options setups generated by AI based on today's ARVN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ARVN

ARVN Technical Chart ARVN Price Prediction ARVN Earnings Date ARVN Investment Advisor ARVN Fair Price Analyzer ARVN Options Advisor ARVN Options Chain ARVN Options Analysis ARVN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals